Company intelligence / Profile preview

Vickor Medical

Wuhan, Hubei Province, China

Ownership: Private
Development stage: Other

Overview

Vickor Medical develops innovative minimally invasive devices targeting major unmet needs in the cardiovascular field, especially heart failure and structural heart diseases. Its lead programs include atrial shunts, patent foramen ovale occluders, and a transcatheter aortic valve replacement system. The company has achieved significant milestones including selection into China's National Innovative Device Green Channel and FDA Breakthrough Device Designation. Multiple products are in clinical development or have begun multi-center clinical trials.

Therapeutic areas: Cardiovascular
Modalities: DeviceMinimally invasive cardiovascular deviceImplantable medical device
Industry: Implantable Medical Devices

Partnerships

Collaboration with Tsinghua University research team on surgical staplers/minimally invasive surgery equipment

Beyond the preview

Go deeper on Vickor Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vickor Medical.

Explore the full profile